Profiling of differentially expressed MicroRNAs in familial hypercholesterolemia via direct hybridization

被引:4
|
作者
Cione, Erika [1 ]
Mahjoubin-Tehran, Maryam [2 ]
Bacchetti, Tiziana [3 ]
Banach, Maciej [4 ,5 ,6 ]
Ferretti, Gianna [7 ,8 ]
Sahebkar, Amirhossein [2 ,9 ]
机构
[1] Univ Calabria, Dept Pharm Hlth & Nutr Sci, Via Savinio, I-87036 Arcavacata Di Rende, CS, Italy
[2] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Biotechnol Res Ctr, Mashhad, Razavi Khorasan, Iran
[3] Marche Polytech Univ, Dept Life & Environm Sci, Via Brecce Bianche, I-60131 Ancona, Italy
[4] Med Univ Lodz MUL Lodz, Dept Prevent Cardiol & Lipidol, Lodz, Poland
[5] Univ Zielona Gora, Cardiovasc Res Ctr, Zielona Gora, Poland
[6] Johns Hopkins Univ, Sch Med, Ciccarone Ctr Prevent Cardiovasc Dis, Dept Med,Div Cardiol, 600 N Wolfe St,Carnegie 591, Baltimore, MD 21287 USA
[7] Marche Polytech Univ, Dept Clin Sci & Odontostomatol, Via Brecce Bianche, I-60131 Ancona, Italy
[8] Marche Polytech Univ, Ctr Obes, I-60131 Ancona, Italy
[9] Mashhad Univ Med Sci, Appl Biomed Res Ctr, Mashhad, Razavi Khorasan, Iran
来源
NON-CODING RNA RESEARCH | 2024年 / 9卷 / 03期
关键词
Familial hypercholesterolemia; Microarray; miRNAs; IN-VIVO; DIAGNOSIS; CELLS;
D O I
10.1016/j.ncrna.2024.02.017
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Individuals with homozygous familial hypercholesterolemia (HoFH) have a severe clinical problem in their first decade of life, which is not usually present in heterozygous FH (HeFH) individuals. For this latter group of patients, FH diagnosis is mostly severely delayed with a significant increase in the risk of angina, myocardial infarction, peripheral artery disease, stroke, and cardiovascular and all-cause mortality. Methods: This study used various bioinformatics tools to analyze microarray data and identify critical miRNAs and their target genes associated with FH and its severity. Differentially expressed serum miRNAs from direct hybridization microarray data in three groups of subjects: healthy, HeFH, and HoFH. The differential expressed miRNAs were determined according to a log of fold-change (LFC) <-0.5 or >0.5 and of p < 0.05. Then, we assessed their target genes in silico. Gene ontology (GO) enrichment was applied by Cytoscape. The proteinprotein interaction and co-expression network were analyzed by the STRING and GeneMANIA plugins of Cytoscape, respectively. Results: We identified increased expression of circulating hsa-miR-604, hsa-miR-652-5p, and hsa-miR-4451 as well as reduced expression of hsa-miR-3140-3p, hsa-miR-550a-5p, and hsa-miR-363-3p in both group of FH vs. healthy subjects. Higher levels of hsa-miR-1183, hsa-miR-1185-1-3p, hsa-miR-122-5p, hsa-miR-19a-3p, hsa-miR345-3p, and hsa-miR-34c-5p were detected in HeFH in respect to HoFH when compared to healthy subjects. Most upregulated miRNAs mainly affected gene related to cardiac myofibrillogenesis, cholesterol synthesis, RNA editing for apolipoprotein B, and associated with LDL-cholesterol levels. In contrast, down-regulated miRNAs mainly affected gene related to plasma biomarker for coronary artery disease, lipids metabolism, cell adhesion and migration, genetic predictors of type 2 diabetes and cholesterol metabolism. The essential genes were primarily enriched in GO regarding biological regulation, intracellular nucleic acid binding, and the KEGG pathway of TGF-beta signaling. Conclusions: The case-control nature of this study precluded the possibility of assessing the predictive role of the identified differentially expressed miRNAs for cardiovascular events. Therefore, the signature of miRNAs reflecting the pathogenesis of both HeFH and HoFH.
引用
收藏
页码:796 / 810
页数:15
相关论文
共 50 条
  • [31] DIFFERENTIALLY EXPRESSED MicroRNAs IN SMALL CELL LUNG CANCER
    Miko, Edit
    Czimmerer, Zsolt
    Csanky, Eszter
    Boros, Gabor
    Buslig, Julia
    Dezso, Balazs
    Scholtz, Beata
    EXPERIMENTAL LUNG RESEARCH, 2009, 35 (08) : 646 - 664
  • [32] Differentially Expressed MicroRNAs in Pancreatic Cancer Stem Cells
    Jung, Dawoon E.
    Wen, Jing
    Oh, Taeyun
    Song, Si Young
    PANCREAS, 2011, 40 (08) : 1180 - 1187
  • [33] Differentially expressed microRNAs between cattleyak and yak testis
    Chuanfei Xu
    Shixin Wu
    Wangsheng Zhao
    TserangDonko Mipam
    Jingbo Liu
    Wenjing Liu
    Chuanping Yi
    Mujahid ali Shah
    Shumin Yu
    Xin Cai
    Scientific Reports, 8
  • [34] Identification of differentially expressed microRNAs in acute Kawasaki disease
    Chen, Ye
    Ding, Yue-Yue
    Ren, Yan
    Cao, Lei
    Xu, Qiu-Qin
    Sun, Ling
    Xu, Ming-Guo
    Lv, Hai-Tao
    MOLECULAR MEDICINE REPORTS, 2018, 17 (01) : 932 - 938
  • [35] Identification of differentially expressed mature micrornas in bladder cancer
    Enokida, H.
    Ichimi, T.
    Kawamoto, K.
    Toki, K.
    Seki, N.
    Nakagawa, M.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 291 - 291
  • [36] In silico identification of differentially expressed microRNAs in thyroid cancer
    Caglar, Hasan Onur
    Aytatli, Abdulmelik
    Karatas, Omer Faruk
    HUMAN GENE, 2024, 41
  • [37] Microarray analysis of differentially expressed microRNAs in myelodysplastic syndromes
    Wan, Chengyao
    Wen, Jing
    Huang, Ying
    Li, Hongying
    Wu, Wenqi
    Xie, Qiongni
    Liang, Xiaolin
    Tang, Zhongyuan
    Zhao, Weihua
    Cheng, Peng
    Liu, Zhenfang
    MEDICINE, 2020, 99 (27) : E20904
  • [38] In silico screening of differentially expressed microRNAs in lung cancer
    Tomida, Shuta
    Tsujikawa, Koyo
    Takahashi, Takashi
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3486S - 3486S
  • [39] Differentially expressed microRNAs between cattleyak and yak testis
    Xu, Chuanfei
    Wu, Shixin
    Zhao, Wangsheng
    Mipam, TserangDonko
    Liu, Jingbo
    Liu, Wenjing
    Yi, Chuanping
    Shah, Mujahid Ali
    Yu, Shumin
    Cai, Xin
    SCIENTIFIC REPORTS, 2018, 8
  • [40] Identification of 20 microRNAs differentially expressed in bladder cancer
    Robinson, Victoria
    Wiltz, Aimee
    Wille, Mark
    Large, Michael
    Steinberg, Gary
    CANCER RESEARCH, 2009, 69